Journal profile · RESPIRATORY SYSTEM
Pneumon
ISSN 1105-848X · eISSN 1791-4914 · The Hellenic Thoracic Socety (HTS) · Greece
Pneumon: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 3,181; median 157 days to acceptance (30 articles, last 24 months); 21 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Pneumon is published by The Hellenic Thoracic Socety (HTS) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms and Asthma and respiratory diseases, together about 25.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Pneumon publishes original papers of international interest on laboratory and clinical research that are pertinent to lung biology and disease. Clinical and experimental work dealing with all aspects of respiratory medicine, including allied health, cell and molecular biology, epidemiology, immunology, pathology, pharmacology, physiology, intensive and critical care, paediatric respiratory medicine and thoracic surgery are also within the scope of the journal. Full Journal Title: Pneumon ISSN (electronic): 1791-4914 ISSN (printed): 1105-848X Scientific Society: Hellenic Thoracic Society Publisher: European Publishing Publisher Address: Science and Technology Park of Crete Editors: See Editorial Board page Peer Review: Single Blind Publication Frequency: Quarterly (every three months) Publication Medium: Electronic Only Publication website: http://www.pneumon.org/ First Year Published: 1987
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Konstantinos KostikasPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine10.4%
- Respiratory Support and MechanismsMedicine8%
- Asthma and respiratory diseasesMedicine7.2%
- COVID-19 Clinical Research StudiesMedicine6%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.2%
- Tracheal and airway disordersMedicine4.8%
- Pleural and Pulmonary DiseasesMedicine4.4%
- Long-Term Effects of COVID-19Medicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.9LetPub ·
- CiteScore (publisher)
- 0.9Publisher website ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 8OpenAlex ·
- i10-index
- 5OpenAlex ·
- 2-year mean citedness
- 0.78OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 90.11%LetPub ·
Volume
- Articles per year
- 20LetPub ·
Articles by year OpenAlex count · 197 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 9 | 9 | 0 |
| 2025 | 21 | 21 | 8 |
| 2024 | 43 | 43 | 49 |
| 2023 | 36 | 36 | 42 |
| 2022 | 29 | 29 | 64 |
| 2021 | 42 | 24 | 132 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
157 daysMedian, submission to acceptance · P25–P75 100 days – 242 days
- Acceptance to online
- median 20 days (29 articles)
- Submission to online
- median 216 days
- Sample
- 30 articles with submission and acceptance dates (33 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 2,950 | — | — | |
| LetPub | EUR 2,950 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≥ 3
- Reference style
- AMA
- Templates
- Word
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review
- Authorship
Authors are encouraged to consult previous relevant publications in Pneumon when preparing manuscripts. Model summary
The authors are encouraged to consult previous relevant publications in Pneumon to assist them in the preparation of the manuscript, especially the references and tables.
Source ↗Publisher website ·- Conflicts of interest
Competing interests must be declared for each author. Model summary
Declare any competing interests for each author.
Source ↗Publisher website ·- Data availability
Authors must include a data availability statement choosing one of five listed options. Model summary
We ask all authors to include a data availability statement by choosing one of the following options during their submission
Source ↗Publisher website ·- Publication ethics
Research involving human subjects must be reviewed and approved by an ethics committee prior to submission. Model summary
All research involving human objects must have been reviewed and approved by an ethics committee prior to submission.
Source ↗Publisher website ·- Peer review
Single blind peer review; reviewer names are not revealed to authors. Model summary
All papers submitted for publication are assessed with the single blind anonymity rule, as to the names of the reviewers observed.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- The Hellenic Thoracic Socety (HTS)
- Country or region
- Greece
- Language
- English
- ISSN
- 1105-848X
- Electronic ISSN
- 1791-4914
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Pneumon
What CAS zone is Pneumon in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pneumon is in Zone 4 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Pneumon?
Based on the dates recorded on 30 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 157 days (interquartile range 100–242 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pneumon?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≥ 3; Reference style: AMA; Templates: Word; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Pneumon?
According to LetPub and DOAJ records, Pneumon is indexed in ESCI and Scopus. The journal's website also lists Web of Science and Embase; that list has not been checked against each database.
Is Pneumon open access, and what is the APC?
Pneumon is a fully open-access journal. APC about USD 3,181.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .